BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 17394460)

  • 1. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
    J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
    Park SW; Yi JH; Miranpuri G; Satriotomo I; Bowen K; Resnick DK; Vemuganti R
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1002-12. PubMed ID: 17167171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
    Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
    Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia.
    Patzer A; Zhao Y; Stöck I; Gohlke P; Herdegen T; Culman J
    Eur J Neurosci; 2008 Nov; 28(9):1786-94. PubMed ID: 18973594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat.
    Zuhayra M; Zhao Y; von Forstner C; Henze E; Gohlke P; Culman J; Lützen U
    Neuropathol Appl Neurobiol; 2011 Dec; 37(7):738-52. PubMed ID: 21366664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroascorbic acid normalizes several markers of oxidative stress and inflammation in acute hyperglycemic focal cerebral ischemia in the rat.
    Bémeur C; Ste-Marie L; Desjardins P; Vachon L; Butterworth RF; Hazell AS; Montgomery J
    Neurochem Int; 2005 Apr; 46(5):399-407. PubMed ID: 15737438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of peroxisome proliferator-activated receptor γ, and effects of its agonist, rosiglitazone, on transient cerebral ischemic damage.
    Lee CH; Park OK; Yoo KY; Byun K; Lee B; Choi JH; Hwang IK; Kim YM; Won MH
    J Neurol Sci; 2011 Jan; 300(1-2):120-9. PubMed ID: 20880548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain.
    Zhao Y; Patzer A; Gohlke P; Herdegen T; Culman J
    Eur J Neurosci; 2005 Jul; 22(1):278-82. PubMed ID: 16029218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone.
    Cuartero MI; Ballesteros I; Moraga A; Nombela F; Vivancos J; Hamilton JA; Corbí ÁL; Lizasoain I; Moro MA
    Stroke; 2013 Dec; 44(12):3498-508. PubMed ID: 24135932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection by rosiglitazone in transient focal cerebral ischemia might not be mediated by glutamate transporter-1.
    Verma R; Mishra V; Gupta K; Sasmal D; Raghubir R
    J Neurosci Res; 2011 Nov; 89(11):1849-58. PubMed ID: 21826699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of cerebral peroxisome proliferator-activated receptors gamma exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus.
    Yu X; Shao XG; Sun H; Li YN; Yang J; Deng YC; Huang YG
    Brain Res; 2008 Mar; 1200():146-58. PubMed ID: 18289512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
    Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
    J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of JNK phosphorylation as a mechanism for rosiglitazone in neuroprotection after transient cerebral ischemia: activation of dual specificity phosphatase.
    Okami N; Narasimhan P; Yoshioka H; Sakata H; Kim GS; Jung JE; Maier CM; Chan PH
    J Cereb Blood Flow Metab; 2013 Jan; 33(1):106-14. PubMed ID: 23032483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia.
    Sundararajan S; Gamboa JL; Victor NA; Wanderi EW; Lust WD; Landreth GE
    Neuroscience; 2005; 130(3):685-96. PubMed ID: 15590152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of signal transducer and activator of transcription-3 by a peroxisome proliferator-activated receptor gamma agonist contributes to neuroprotection in the peri-infarct region after ischemia in oophorectomized rats.
    Kinouchi T; Kitazato KT; Shimada K; Yagi K; Tada Y; Matsushita N; Sumiyoshi M; Satomi J; Kageji T; Nagahiro S
    Stroke; 2012 Feb; 43(2):478-83. PubMed ID: 22076002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion.
    Gamboa J; Blankenship DA; Niemi JP; Landreth GE; Karl M; Hilow E; Sundararajan S
    Neuroscience; 2010 Oct; 170(3):846-57. PubMed ID: 20691766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
    Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
    J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARγ agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats.
    Zhang Q; Hu W; Meng B; Tang T
    Neurol Res; 2010 Oct; 32(8):852-9. PubMed ID: 20350367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.